IGF-1LR3 IG01 0.1mg*10vials

IGF-1 LR3 IG01 0.1mg*10 vials is a high-purity, long-acting recombinant insulin-like growth factor-1 analog research peptide with the classic Long R3 structural modification. This variant is based on an optimized natural IGF-1 molecular framework, replacing the third amino acid and adding a 13-amino acid N-terminal extension, resulting in an ultra-long half-life and ultra-low binding affinity to IGF-binding protein (IGFBP). Compared to conventional short-acting IGF-1, IG01 completely avoids encapsulation and inactivation by endogenous IGFBP3/IGFBP1, achieving free and stable targeted binding efficiency in vivo. It overcomes the limitations of traditional growth hormone-dependent pathway activation, directly targeting downstream IGF-1 signaling pathways, making it a core independent material for research on cell proliferation regulation, metabolic remodeling, and anti-aging mechanisms. The purified 0.1mg standard medium specification is perfectly suited for routine gradient modeling, cell culture intervention, tissue growth studies, and validation of synergistic effects of complex peptides, and is widely applicable to preclinical physiological mechanisms and cutting-edge pharmacological research.

Product Functions and Research Value

In systematic laboratory studies, IGF-1 LR3 IG01 effectively activates the core downstream signaling pathway of PI3K/Akt/mTOR, independently regulating the balance of somatic cell proliferation, differentiation, survival, and apoptosis. Unlike HGH products that indirectly increase IGF-1 levels through pituitary stimulation, IG01 directly provides bioactive, long-acting IGF-1, achieving direct, rapid, and sustained promotion of cell growth, enhanced lean tissue anabolism, regulation of glucose metabolism, and inhibition of cellular senescence. Its core research value is reflected in four main aspects: First, it effectively promotes muscle cell proliferation and repair, accelerating lean tissue reconstruction and growth; second, it optimizes peripheral glucose uptake and insulin signal transduction, intervening in insulin resistance metabolic models; third, it inhibits oxidative stress and apoptosis, delaying tissue aging; fourth, it synergistically works with growth hormone peptides to construct a complete growth hormone/insulin-like growth factor-1 axis positive feedback model, significantly enhancing the overall metabolic and anabolism intervention effects. The 0.1mg formulation offers stable, long-lasting activity and low experimental variability, making it suitable for long-term, repetitive intervention studies. It provides highly reproducible and authoritative standard data for cell biology, metabolic pharmacology, and anti-aging mechanism research.

Core Product Advantages

1. Exclusive LR3 Long-Acting Modification Structure: A unique, optimized long-acting LR3 structure effectively resists binding and inactivation by endogenous IGFBP protein, significantly extending the molecular half-life and achieving long-lasting therapeutic effects, overcoming the problems of short half-life and rapid decay of natural IGF-1.

2. Direct and Independent Pathway Activation: Independent of endogenous growth hormone secretion and pituitary function. It directly supplements active IGF-1, activating downstream anabolic and metabolic pathways, resulting in faster onset of action and more significant experimental phenotypes, compensating for the indirect effects of single growth hormone research materials.

3. Classic Balanced Standard 0.1mg Formulation: A universally applicable and moderate dose suitable for mainstream laboratory studies, balancing sufficient biological activity and experimental safety. Suitable for daily dose gradient screening, long-term cell intervention, and peptide compound validation, it has broad application adaptability. 4. High-purity recombinant active peptide purification process: Utilizing advanced recombinant protein purification and vacuum freeze-drying technology, the peptide exhibits high activity, is free from foreign protein contamination, ensures ultrapure experimental variables, and guarantees accurate and reliable research conclusions.

5. Standard aseptic integrated packaging: Packaged in 10-vial aseptic packs, each batch undergoes rigorous HPLC purity testing and comes with a complete Certificate of Account (COA). Stable activity, long shelf life, and suitable for university laboratories, preclinical drug development, and bulk wholesale purchases.

IGF-1 LR3 IG01 0.1mg*10 vials is a high-purity, long-acting recombinant insulin-like growth factor-1 (IGF-1) research peptide, employing the classic Long R3 long-acting modified structure. Based on the natural IGF-1 molecular backbone, this product undergoes site-specific amino acid substitution and N-terminal 13-peptide extension modification, possessing two core characteristics: an ultra-long half-life and extremely low affinity for IGF-binding proteins. Compared to ordinary short-acting IGF-1, IG01 is more effective...